Central Serous Chorioretinopathy: Etiology, Course and Prognosis
Pathogenesis of central serous chorioretinopathy is not entirely understood yet, therefore further investigations are needed. During this study patients with an acute episode of central serous chorioretinopathy are observed with established ophthalmologic methods (multimodal imagine) every 6 weeks until subretinal fluid is reabsorbed to gain further insides in etiology, course and prognosis of this disease.
Central Serous Chorioretinopathy
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Central Serous Chorioretinopathy: An Observational Study About Etiology, Course and Prognosis|
- Clinical Outcome [ Time Frame: 2 years ] [ Designated as safety issue: No ]OCT, Visus
- Subclinical Data [ Time Frame: 2 years ] [ Designated as safety issue: No ]FA findings, retinal sensitivity in Microperimetry, contrast sensitivity, Amsler Grid Test
|Study Start Date:||April 2011|
|Study Completion Date:||April 2013|
|Primary Completion Date:||April 2013 (Final data collection date for primary outcome measure)|
Patients with central serous chorioretinopathy are recruited from the Department of Ophthalmology at the Medical University of Vienna. All patients undergo ETDRS visual acuity measurement, Pelli-Robson contrast examination, Amsler-Grid testing, questionnaire testing, ophthalmologic examination, SD-OCT and polarization-sensitive OCT, fundus autofluorescence, fluorescein angiography, indocyanine-green angiography, fundus photo and microperimetry. Patients are re-examined after an interval of 6 weeks until subretinal fluid is entirely reabsorbed to gain further insides in etiology, course and prognosis of this disease.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01378130
|Vienna Gerenal Hospital|
|Principal Investigator:||Stefan Sacu, Ass.Prof.Dr.||Department of Ophthalmology, Medical University of Vienna, Austria|